H
Hedvig Nordeng
Researcher at University of Oslo
Publications - 247
Citations - 6403
Hedvig Nordeng is an academic researcher from University of Oslo. The author has contributed to research in topics: Pregnancy & Medicine. The author has an hindex of 40, co-authored 209 publications receiving 4911 citations. Previous affiliations of Hedvig Nordeng include University of Toronto & Norwegian Institute of Public Health.
Papers
More filters
Journal ArticleDOI
Medication use in pregnancy: a cross-sectional, multinational web-based study.
Angela Lupattelli,Olav Spigset,Michael J. Twigg,Ksenia Zagorodnikova,A C Mårdby,Myla E Moretti,Mariola Drozd,Alice Panchaud,Katri Hämeen-Anttila,André Rieutord,R. Gjergja Juraški,Marina Odalovic,Debra Kennedy,Gorazd Rudolf,Herbert Juch,Anneke Passier,Ingunn Björnsdóttir,Hedvig Nordeng,Hedvig Nordeng +18 more
TL;DR: The majority of women in Europe, North America, South America and Australia used at least one medication during pregnancy, and there was a substantial inter-region variability in the types of medication used.
Journal ArticleDOI
Use of herbal drugs in pregnancy: a survey among 400 Norwegian women
Hedvig Nordeng,Gro C. Havnen +1 more
TL;DR: To investigate the use of herbal drugs by pregnant women, a large number of women in Northern Ireland are taking herbal drugs, including cannabis, which are believed to be safe and effective for pregnant women.
Journal ArticleDOI
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study
TL;DR: Children exposed to long-term use of paracetamol during pregnancy had substantially adverse developmental outcomes at 3 years of age, and Ibuprofen exposure was not associated with neurodevelopmental outcomes.
Journal ArticleDOI
Perception of risk regarding the use of medications and other exposures during pregnancy.
TL;DR: Women overestimate the risk of drug use and other exposures during pregnancy, and it is important for health care providers to use evidence-based information, to reduce unnecessary anxiety, and to ensure safe and appropriate treatment during pregnancy.
Journal ArticleDOI
Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
TL;DR: Five cases of neonatal withdrawal syndrome after third trimester in utero SSRI exposure are reported, with Symptoms were irritability, constant crying, shivering, increased tonus, eating and sleeping difficulties and convulsions.